Conditions: Head and Neck Cancer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 94
Healthy volunteers: no

Brief summary:
To investigate the efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer following administration of rebamipide and to determine the optimal dose of rebamipide.

Detailed description:

Arms:
arm 1: 6 times daily arm 2: 6 times daily arm 3: 6 times daily

Interventions: intervention 1: Placebo intervention 2: 2% Rebamipide liquid intervention 3: 4% Rebamipide liquid
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: